(Date:5/15/2008)...irst in human clinical data highlight safety profi...anced solid tumors -, BRISBANE, Calif., May 15 /P...ld biopharmaceutical company developing novel canc... its lead PARP inhibitor, BSI-201, will,be present...gy annual,meeting in Chicago., Findings will be p...
(Date:5/15/2008)...LBOURNE, Australia, May 15 /PRNewswire-FirstCall/ ... the abstract for its upcoming oral,presentation o...n Society,of Clinical Oncology (ASCO) will be acce...ww.asco.org ) from 9pm on Thursday 15 May (US EDT)...ation of CYT997, a novel,cytotoxic and vascular di...
(Date:5/15/2008)...pressure reductions demonstrated in Blacks, Hispan... and Obese Individuals, PARSIPPANY, N.J., May 15 ...day that data presented at the American Society of...eting (ASH 2008) in New,Orleans demonstrated that ... and olmesartan medoxomil) safely and effectively ...
(Date:5/15/2008)...N ARBOR, Mich. and TOULOUSE, France, May 15 /PRNew...vately held pharmaceutical company,developing HDL-...lar and,metabolic diseases, today announced that i...02, one of the company,s lead product candidates.,...eptor (PPAR),delta-specific agonist in development...
Breaking Medicine Technology:BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital 3507 1Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital 3507 2MEDIA ADVISORY 3A New York Lt Gov David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit 12693 1MEDIA ADVISORY 3A New York Lt Gov David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit 12693 2China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd 12691 1China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd 12691 2China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd 12691 3China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd 12691 4ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting 3506 1ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting 3506 2ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting 3506 3...N.J. and BRISTOL, Tenn., May 09, 2007,/PRNewswire-...Pharmaceuticals, Inc. today announced plans to pre...tudies of men with erectile,dysfunction (ED). The ...ant Professor, Department of Urology, NYU School o...sychology, Case Western,Reserve School of Medicine...
...STATION, N.J.--(BUSINESS WIRE)-May 10, 2007--Today...g results from two,Phase III studies of Merck,s ce...n Papillomavirus (Types 6, 11, 16, 18),Recombinant...00,percent protection against cervical, vaginal an...dasil is designed to protect,against, HPV types 6,...
Other Medicine Technology:Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction 2Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction 3Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 2New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 3New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 5New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 6New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 7New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 8New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 9New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 10New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 11New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 12New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 13New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 14New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 15New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 16New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 17New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 18New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 19New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 20New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 21New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 22New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 23New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 24New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 25New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 26New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 27New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 28New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 29New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 30New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 31New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 32(Date:5/16/2008)...ntry needs is more unemployed politicians - and ec...tCall/ -- Although nearly all,voters place health ...ist,a looming federal budgetary crunch means none...urrent presidential candidates is likely to become...y Leader Bill Frist., Jousting with Princeton Uni...
(Date:5/16/2008)...year-old Chinese students learn the lesson of help...uan earthquake, NANJING, China, May 16 /PRNewswir...earthquake, even the youngest members of China are...ef efforts. All around the,country, schools are ru...Led by the school,s principal, Ms. Zhang Lijun, th...
(Date:5/16/2008)...May 16 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Na...he treatment of cardiac,arrhythmias, announced tod...oCor common stock filed a complaint in the Superio...Diego, naming as defendants each member of the,Boa...entific Corporation.,The complaint is styled Secon...
(Date:5/16/2008)...Y., May 16 /PRNewswire-USNewswire/ -- Karin Weisbu...he nonprofit publisher of,Consumer Reports magazin...of the Year at CU,s Yonkers headquarters today., ...d. She bundles up in,the winter and rides in shirt...akes her along Quaker Ridge in New Rochelle, down ...
Breaking Medicine News(10 mins):Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 2Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 3For implantation in proximal interphalangeal joints of the lateral toes to correct deformity associated with degenerative or rheumatoid arthritis.
...g a new standard in the field of hammertoe implant... medical grade silicone, these durable and lasting...l of flexibility while maintaining correct toe len...ing stiffnesses. Lengths are determined by the sur...
...rapy has been approved for use as an adjunctive th...lts and adolescents over 12 years of age with part...eptic medications. This indication is based on out..., measured as median seizure reduction, was observ...
...Cortical Mapping Unit offers you a convenient and ...ortex during surgery. To maximize the field of vie...ently over the site. In addition, the cranial clam...each sterile, disposable electrode has its own sph...
Medicine Products: